Fresenius Purchase of NxStage Delayed Until August by FTC

The government shutdown delayed FTC approval of a Fresenius acquisition of NxStage Medical, Inc. The transaction is now expected to close in August 2019.

Read the full article » | Posted 02-14-2019

Related Articles

• Outset Halts Tablo Sales for Home Use Pending FDA Review of New Features Posted 07-13-2022
• Baxter Showcases Kidney Care Products Posted 06-10-2022
• DaVita and Medtronic to Launch New Kidney Tech Company Posted 06-10-2022
• Outset Tablo Could Boost Use of Home Hemodialysis Posted 05-12-2022